Knight Amends Normal Course Issuer Bid

This section is Partnership Content suppliedThe content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire Article contentMONTREAL, March 23, 2026 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX:GUD) (“Knight” or the “Company“), a pan-American (ex-US) specialty pharmaceutical company, announced today acceptance by the Toronto Stock Exchange (the “TSX“) to amend the Company’s previously announced Notice of Intention to Make a Normal Course Issuer Bid (“NCIB“) to increase the maximum number of common shares (the “Common Shares”) that it intends to repurchase for cancellation during the 12-month period ending August 21, 2026, from 3,000,000 Common Shares to 6,190,493 Common Shares, representing approximately 10% of the public float of Common Shares as at August 8, 2025. All other terms and conditions of the NCIB remain unchanged.Sign In or Create an AccountEmail AddressContinueor View more offersArticle contentArticle contentThe Common Shares may be purchased for cancellation through the facilities of the TSX or through alternative Canadian trading systems at times and in numbers to be determined by the Company. During the period from August 22, 2025 to March 19, 2026 inclusively, the Company purchased 1,767,300 Common Shares through the facilities of the TSX and alternative Canadian trading systems at a weighted average price per share of $6.08.Article contentWe apologize, but this video has failed to load.Try refreshing your browser, ortap here to see other videos from our team.Article contentTop StoriesGet the latest headlines, breaking news and columns.There was an error, please provide a valid email address.Sign UpBy signing up you consent to receive the above newsletter from Postmedia Network Inc.Thanks for signing up!A welcome email is on its way. If you don't see it, please check your junk folder.The next issue of Top Stories will soon be in your inbox.We encountered an issue signing you up. Please try againInterested in more newsletters? Browse here.Article contentKnight has amended its automatic share purchase plan (“ASPP”) with its broker to reflect the increased number of Common Shares authorized for repurchase under the amended NCIB. Under the ASPP, Knight’s broker may repurchase Common Shares which it would ordinarily not be permitted to due to regulatory restrictions or self-imposed blackout periods.Article contentAbout Knight Therapeutics Inc.Article contentKnight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing and commercializing pharmaceutical products for Canada and Latin America. Knight’s Latin American subsidiaries operate under United Medical, Biotoscana Farma and Laboratorio LKM.

Knight Therapeutics Inc.’s Common Shares trade on TSX under the symbol GUD. For more information about Knight Therapeutics Inc., please visit the company’s web site at www.knighttx.com or www.sedarplus.ca.Article contentArticle contentForward-Looking StatementArticle contentThis document contains forward-looking statements for Knight Therapeutics Inc. and its subsidiaries. These forward-looking statements, by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements.

Knight Therapeutics Inc. considers the assumptions on which these forward-looking statements are based to be reasonable at the time they were prepared but cautions the reader that these assumptions regarding future events, many of which are beyond the control of Knight Therapeutics Inc. and its subsidiaries, may ultimately prove to be incorrect. Factors and risks which could cause actual results to differ materially from current expectations are discussed in Knight Therapeutics Inc.’s Annual Report and in Knight Therapeutics Inc.’s Annual Information Form for the year ended December 31, 2025, as filed on www.sedarplus.ca.

Knight Therapeutics Inc. disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information or future events, except as required by law.Article contentCONTACT INFORMATION:Article contentInvestor Contact: Knight Therapeutics Inc.

Samira Sakhia Arvind UtchanahPresident & Chief Executive Officer Chief Financial OfficerT: 514.484.4483 T. +598.2626.2344F: 514.481.4116 Email: IR@knighttx.com Email: IR@knighttx.comWebsite: www.knighttx.com Website: www.knighttx.comArticle contentArticle contentArticle contentArticle contentArticle contentArticle contentArticle contentTrending Subscriber only. Hey Canadians, want to build a pipeline? Your pension might just help you do it Subscriber only Investor Garry Marr: Why it could be the right time to walk away from your real estate Personal Finance How the Fed’s oil shock blind spot affects gold and other investments, and may engineer a recession Investor Two pilots dead after Air Canada jet hits fire truck at New York airport Airlines TC Energy could be open to return to B.C. LNG pipeline project as global gas crunch threatens Oil & Gas Share this article in your social networkCommentsYou must be logged in to join the discussion or read more comments.Create an AccountSign in Join the Conversation Postmedia is committed to maintaining a lively but civil forum for discussion. Please keep comments relevant and respectful. Comments may take up to an hour to appear on the site. You will receive an email if there is a reply to your comment, an update to a thread you follow or if a user you follow comments. Visit our Community Guidelines for more information. Subscriber only. Hey Canadians, want to build a pipeline? Your pension might just help you do it Subscriber only Investor Garry Marr: Why it could be the right time to walk away from your real estate Personal Finance How the Fed’s oil shock blind spot affects gold and other investments, and may engineer a recession Investor Two pilots dead after Air Canada jet hits fire truck at New York airport Airlines TC Energy could be open to return to B.C. LNG pipeline project as global gas crunch threatens Oil & Gas